Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition (original) (raw)
Related papers
Journal of Biological Chemistry, 2000
Dual-Action Kinase Inhibitors Control p38α MAP Kinase Threonine Dephosphorylation
bioRxiv (Cold Spring Harbor Laboratory), 2024
Protein kinase CK2 – A key suppressor of apoptosis
Advances in Enzyme Regulation, 2008
Biochemistry, 2006
Designing bisubstrate analog inhibitors for protein kinases
Pharmacology & Therapeutics, 2002
The Stress-activated Protein Kinases
Annals of the New York Academy of Sciences, 1995
Cancer Research, 2013
Modulation of Sensitivity to Antitumor Agents by Targeting the MAPK Survival Pathway
Current Pharmaceutical Design, 2012
Protein kinase CK2: a catalyst for biology, medicine and structural biochemistry
Molecular and Cellular Biochemistry, 2011
Abstract A057: The MEK1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma
Cancer Stem Cells, 2019
A novel anti-melanoma SRC-family kinase inhibitor
Oncotarget, 2019
Selectivity of Docking Sites in MAPK Kinases
Journal of Biological Chemistry, 2009
Journal of Molecular Biology, 2005
Methods, 2006
Discovery of 4-alkylamino-7-aryl-3-cyanoquinoline LRRK2 kinase inhibitors
Bioorganic & Medicinal Chemistry Letters, 2013
Discovery of novel FMS kinase inhibitors as anti-inflammatory agents
Bioorganic & Medicinal Chemistry Letters, 2008
Journal of Medicinal Chemistry, 2011
Downregulation of protein kinase C-γ is independent of a functional kinase domain
FEBS Letters, 1991
Journal of Biological Chemistry, 1996
Kinase Inhibitors from Marine Sponges
Marine Drugs, 2011
Specific delivery of kinase inhibitors in nonmalignant and malignant diseases
Expert Opinion on Drug Delivery, 2011
Negative regulation of receptor tyrosine kinase signals
FEBS Letters, 2001
Growth Inhibition of Multiple Myeloma Cells by a Novel I B Kinase Inhibitor
Clinical Cancer Research, 2005